CA Patent

CA2267049A1 — Pharmaceutical compositions

Assigned to Bioglan Laboratories Ltd · Expires 2000-08-05 · 26y expired

What this patent protects

The present invention relates to a pharmaceutical composition comprising a nitrate vasodilator and a compound of formula I: (see formula I)

USPTO Abstract

The present invention relates to a pharmaceutical composition comprising a nitrate vasodilator and a compound of formula I: (see formula I)

Drugs covered by this patent

Qutenza (CAPSAICIN) · Averitas

Patent Metadata

Patent number: CA2267049A1
Jurisdiction: CA
Classification: —
Expires: 2000-08-05
Drug substance claim: No
Drug product claim: No
Assignee: Bioglan Laboratories Ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.